Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

ADMA Biologics Inc (ADMA)

Healthcare Biotechnology
8.50 $
-2.4% vs. previous close
Closing price · As of: 31. Jul 2026

Who owns ADMA Biologics Inc (ADMA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 97.8% of the shares are freely tradable; institutional investors hold 94.0%.

Ownership Structure

Institutional ownership
94.0%
Insiders
1.9%
Float
97.8%
Short % of float
11.2%
Shares Outstanding
232Mio.

Largest Shareholders

Institutions

Institutions ADMA
Name Stake (%) Shares Change (%) Date
BlackRock Inc 15.85 36,830,774 +1.4 03/31/2026
Vanguard Group Inc 8.98 20,854,669 -0.6 12/31/2025
State Street Corp 6.06 14,084,205 +3.6 03/31/2026
Capital Research Global Investors 4.82 11,191,116 +68.6 03/31/2026
Vanguard Capital Management, LLC 4.44 10,306,871 +0.0 03/31/2026
Vanguard Portfolio Management, LLC 3.82 8,868,657 +0.0 03/31/2026

Funds

Funds ADMA
Name Stake (%) Shares Change (%) Date
iShares Core S&P Small-Cap ETF 6.21 14,425,192 +0.0 05/29/2026
American Funds SMALLCAP World A 4.42 10,279,994 +94.1 03/31/2026
First Trust NYSE Arca Biotech ETF 3.43 7,962,799 -0.4 05/31/2026
Vanguard Total Stock Mkt Idx Inv 3.13 7,265,093 +0.3 04/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
24. Jul 2026 Kestenberg-Messina Kaitlin M. COO and SVP, Compliance Other 3,177 8.37 26,591
16. Jul 2026 Kohler Terry CFO and Treasurer Other 85,130 0.00

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?